全网公布的依普利酮2025年最新价格

Eplerenone is an aldosterone antagonist mainly used to treat heart failure and hypertension after myocardial infarction. In 2025, the global price of eplerenone varies depending on the manufacturer and specification. Huizhi of the United States and Luping of India are the two major manufacturers, and prices are relatively stable. Eplerenone has been marketed in many countries, and its medication preparation requires strict compliance with medical instructions, especially monitoring of serum potassium and renal function.

The latest price of eplerenone in 2025 published on the entire network

In 2025, the price will change due to different manufacturers and specifications. The following is the price information of the two main versions, which is for patient reference only. The actual price must prevail when purchasing.

American Huizhi version

The specification of eplerenone produced by American Huizhi is 50mg*100 tablets, and the price is about US$85 per box. This version has become the first choice for many patients due to its stable quality and wide market acceptance.

Indian Lupine version

The specifications of eplerenone produced by India Lupine are 50mg*150 tablets, and the price is about US$88 per box. The Indian version is more competitively priced and suitable for patients who require long-term medication.

There is no significant difference in efficacy between the two versions of eplerenone, and patients can choose the appropriate version according to their own needs and economic conditions.

Global marketing status of eplerenone

Eplerenone has been approved for marketing in many countries and regions around the world and is widely used in clinical treatment.

U.S. market

Eplerenone was first approved in the United States in 2002 for the treatment of heart failure and hypertension after myocardial infarction. The US market is mainly supplied by Huizhi Company, and the price is relatively high.

Indian market

India is one of the major producers of eplerenone. The generic drugs produced by Luping Company are relatively low-priced and suitable for the needs of patients in developing countries.

Other regions

Eplerenone is also sold in Europe, Asia and South America, and prices and availability vary by region.

Globally, eplerenone has become one of the important drugs for the treatment of heart failure and hypertension due to its remarkable efficacy and safety.

Eplerenone medication preparation

Before using eplerenone, patients need to make comprehensive medication preparations.

Serum potassium monitoring

Serum potassium levels must be measured before starting treatment and monitored regularly during treatment. Excessive serum potassium may lead to hyperkalemia, and the dose needs to be adjusted in time.

Evaluation of renal function

Eplerenone should be used with caution in patients with renal insufficiency. This drug is contraindicated in patients with creatinine clearance less than 30 mL/min.

Drug interactions

When eplerenone is used together with strong CYP3A inhibitors (such as ketoconazole), the dose needs to be adjusted to avoid adverse reactions.

Strictly following medical instructions and medication guidelines can effectively exert the therapeutic effect of eplerenone while reducing the occurrence of adverse reactions.